Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Artificial intelligence models in chronic lymphocytic leukemia - recommendations toward state-of-the-art

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Pancreatitis-associated protein as an early marker of asparaginase-associated pancreatitis

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  4. Mutations known from B-cell lymphoid malignancies are not found in CD34+ stem cells from patients with lymphoma

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

Vis graf over relationer

We investigated trends of survival in a population-based cohort study of all 181 adults who received HCT for ALL in Denmark between 2000-2019. Patients had a median (min-max) age of 36 (18-74) years at HCT and were followed for a median of eight years. Overall survival (OS) improved over time with an estimated 2-year OS of 49% (CI 27-66%) in year 2000 versus 77% (CI 59-88%) in year 2019. More patients achieved cure over time (OR for cure per year 1.07, CI 1.00-1.15), while the rate of death in non-cured patients remained stable (HR of excess mortality per year 0.99, CI 0.93-1.06). Relapse decreased over time (HR 0.92 per year, CI 0.87-0.98), whereas non-relapse mortality did not change notably (HR 0.98 per year, CI 0.93-1.04). In conclusion, survival after HCT in adults with ALL has improved over the past two decades, primarily due to more patients achieving cure.

TidsskriftLeukemia and Lymphoma
Udgave nummer2
Sider (fra-til)416-425
Antal sider10
StatusUdgivet - feb. 2022

ID: 69934084